{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:58:20Z","timestamp":1784757500398,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001412"],"award-info":[{"award-number":["UL1TR001412"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008487","name":"Cure Parkinson's Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008487","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ibneur.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:55:18Z","timestamp":1773474918000},"page":"506-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lithium\u2019s effects on serum neurofilament light in Parkinson\u2019s disease: A post hoc analysis"],"prefix":"10.1016","volume":"20","author":[{"suffix":"Jr.","given":"Thomas","family":"Guttuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0893-4620","authenticated-orcid":false,"given":"Daniel","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory E.","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.4088\/JCP.13m08741","article-title":"Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension","volume":"75","author":"Aprahamian","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ibneur.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2012.03.055","article-title":"Lithium and oxidative stress lessons from the MPTP model of Parkinson's disease","volume":"516","author":"Arraf","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2026.03.003_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/gerona\/glaa176","article-title":"Person-specific contributions of brain pathologies to progressive parkinsonism in older adults","volume":"76","author":"Buchman","year":"2021","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"10.1016\/j.ibneur.2026.03.003_bib4","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/awx146","article-title":"Progression marker of Parkinson's disease: a 4-year multi-site imaging study","volume":"140","author":"Burciu","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2026.03.003_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/brain\/awad388","article-title":"Nigrostriatal tau pathology in parkinsonism and Parkinson's disease","volume":"147","author":"Chu","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3835(82)90060-X","article-title":"Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat","volume":"16","author":"Columbano","year":"1982","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ibneur.2026.03.003_bib7","doi-asserted-by":"crossref","first-page":"e1201","DOI":"10.1212\/WNL.0000000000009097","article-title":"Blood neurofilament light levels segregate treatment effects in multiple sclerosis","volume":"94","author":"Delcoigne","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12974-014-0140-4","article-title":"Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K\/Akt\/FoxO1 pathway","volume":"11","author":"Dong","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ibneur.2026.03.003_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","article-title":"Concomitant pathologies among a spectrum of parkinsonian disorders","volume":"20","author":"Dugger","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2026.03.003_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2019.01.009","article-title":"Could high lithium levels in tobacco contribute to reduced risk of Parkinson's disease in smokers?","volume":"397","author":"Guttuso","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ibneur.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ibneur.2023.05.001","article-title":"Lithium's effects on therapeutic targets and MRI biomarkers in Parkinson's disease: A pilot clinical trial","volume":"14","author":"Guttuso","year":"2023","journal-title":"IBRO Neurosci. Rep."},{"key":"10.1016\/j.ibneur.2026.03.003_bib12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mds.28886","article-title":"Thalamic dorsomedial nucleus free water correlates with cognitive decline in parkinson's disease","volume":"37","author":"Guttuso","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2026.03.003_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2016.07.027","article-title":"Low-dose lithium adjunct therapy associated with reduced off-time in Parkinson's disease: a case series","volume":"368","author":"Guttuso","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ibneur.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12868-015-0222-y","article-title":"Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement","volume":"16","author":"Hou","year":"2015","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ibneur.2026.03.003_bib15","first-page":"39","article-title":"Manic depressive psychosis in India and the possible role of lithium as a natural prophylactic. II--Lithium content of diet and some biological fluids in Indian subjects","volume":"26","author":"Jathar","year":"1980","journal-title":"J. Post. Med"},{"key":"10.1016\/j.ibneur.2026.03.003_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ibneur.2026.03.003_bib17","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jnr.22700","article-title":"Lithium protects against oxidative stress-mediated cell death in alpha-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease","volume":"89","author":"Kim","year":"2011","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.ibneur.2026.03.003_bib18","first-page":"5324","article-title":"Orotic acid enhancement of preneoplastic and neoplastic lesions induced in the pancreas and liver of hamsters by N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine","volume":"54","author":"Kokkinakis","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ibneur.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/carcin\/12.2.181","article-title":"Enhancement of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine-induced tumorigenesis in Sprague-Dawley rats by orotic acid","volume":"12","author":"Kokkinakis","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ibneur.2026.03.003_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2014.10.032","article-title":"Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model","volume":"1591","author":"Lieu","year":"2014","journal-title":"Brain Res"},{"key":"10.1016\/j.ibneur.2026.03.003_bib21","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL: a biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2026.03.003_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bdi.12455","article-title":"Lithiumeter: Version 2.0","volume":"18","author":"Malhi","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ibneur.2026.03.003_bib23","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2026.03.003_bib24","unstructured":"NeurologyLive. FDA Approves Tofersen as First SOD1-ALS Treatment. Available at: \u3008https:\/\/www.neurologylive.com\/view\/fda-approves-tofersen-first-sod1-als-therapy\u3009 Accessed 24 February 2025."},{"key":"10.1016\/j.ibneur.2026.03.003_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2021.07.028","article-title":"Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD)","volume":"90","author":"Niemann","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2026.03.003_bib26","first-page":"305","article-title":"Estimation of extracellular volume from regularized multi-shell diffusion MRI","volume":"15","author":"Pasternak","year":"2012","journal-title":"Med. Image Comput. Comput. Assist Inter."},{"key":"10.1016\/j.ibneur.2026.03.003_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41531-024-00768-1","article-title":"Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson's Disease","volume":"10","author":"Pedersen","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.ibneur.2026.03.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105815","article-title":"Comparison of SIMOA and VEUS technologies for serum neurofilament light chain measurement in multiple sclerosis","volume":"90","author":"Pelisek","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ibneur.2026.03.003_bib29","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1007\/s00415-024-12669-7","article-title":"Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson's disease","volume":"271","author":"Pilotto","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.ibneur.2026.03.003_bib30","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13045","article-title":"Association of lithium use and a higher serum concentration of lithium with the risk of declining renal function in older adults: a population-based cohort study","volume":"81","author":"Rej","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ibneur.2026.03.003_bib31","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","article-title":"Pooled analysis of tobacco use and risk of Parkinson disease","volume":"64","author":"Ritz","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2026.03.003_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200504035","article-title":"Lithium induces autophagy by inhibiting inositol monophosphatase","volume":"170","author":"Sarkar","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ibneur.2026.03.003_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/bdi.12714","article-title":"Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: an ISBD task force report","volume":"21","author":"Shulman","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ibneur.2026.03.003_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","article-title":"Interactions of pathological proteins in neurodegenerative diseases","volume":"134","author":"Spires-Jones","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ibneur.2026.03.003_bib35","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1111\/j.1742-4658.2007.05809.x","article-title":"Lithium increases PGC-1alpha expression and mitochondrial biogenesis in primary bovine aortic endothelial cells","volume":"274","author":"Struewing","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.ibneur.2026.03.003_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson's disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.ibneur.2026.03.003_bib37","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1038\/s41598-023-29704-8","article-title":"Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study","volume":"13","author":"Truffi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2026.03.003_bib38","first-page":"35","article-title":"Prevalence of concomitant pathologies in parkinson's disease: implications for prognosis, diagnosis, and insights into common pathogenic mechanisms","volume":"14","author":"Walker","year":"2024","journal-title":"J. Park. 's. Dis."},{"key":"10.1016\/j.ibneur.2026.03.003_bib39","first-page":"571","article-title":"Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes","volume":"12","author":"Ygland Rodstrom","year":"2022","journal-title":"J. Park. 's. Dis."},{"key":"10.1016\/j.ibneur.2026.03.003_bib40","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.neuropharm.2004.02.005","article-title":"Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax","volume":"46","author":"Youdim","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ibneur.2026.03.003_bib41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fneur.2018.00809","article-title":"Tau Pathology in Parkinson's Disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Neurol."},{"key":"10.1016\/j.ibneur.2026.03.003_bib42","first-page":"4989","article-title":"Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of alphasynuclein methylation","volume":"19","author":"Zhao","year":"2019","journal-title":"Mol. Med. Rep."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126000400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126000400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:14:45Z","timestamp":1782159285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242126000400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"alternative-id":["S2667242126000400"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.03.003","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lithium\u2019s effects on serum neurofilament light in Parkinson\u2019s disease: A post hoc analysis","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}